Warren Buffett - Berkshire Hathaway
As of Q2 2026, Warren Buffett reported 29 long-equity positions worth $299.25B in aggregate.
Copy-investor backtest
- Latest quarter
- +5.97%
- 1-year
- +19.33%
- 3-year
- +55.53%
- 5-year
- +58.09%
- 3-year vs S&P 500
- -17.71%
- 5-year vs S&P 500
- -15.59%
- 5-year top 5
- +78.99%
Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.
Get email alerts when Warren Buffett files a new 13F — sign in or create a free account.
Updated 2026-06-06 from SEC 13F data.
Live quotes available for 19 of 25 rows. Rows without a quote are marked unavailable.
| 1 | PG | Com | 15.65% | - | 37,291,036 | $2.4B | $64.33 | No quote |
| 2 | WSC | Finl Corp. Com | 13.70% | - | 5,703,087 | $2.1B | $368.41 | No quote |
| 3 | WFC | Del Com | 12.54% | - | 62,052,396 | $1.92B | $30.99 | No quote |
| 4 | WMT | Com | 11.92% | - | 33,891,142 | $1.83B | $53.93 | No quote |
| 5 | KFT | Foods Inc. Com | 11.54% | - | 56,164,484 | $1.77B | No quote | No quote |
| 6 | COP | Com | 9.38% | - | 21,109,637 | $1.44B | $68.10 | No quote |
| 7 | AXP | Com | 4.82% | - | 17,225,400 | $739.31M | $42.92 | No quote |
| 8 | USB | Bancorp Com | 4.10% | - | 23,307,300 | $628.6M | $26.97 | No quote |
| 9 | MTB | Com | 2.64% | - | 4,653,026 | $405.05M | $87.05 | No quote |
| 10 | WPO | Cl B | 2.56% | - | 894,304 | $393.05M | No quote | No quote |
| 11 | MCO | Com | 2.20% | - | 12,695,850 | $336.95M | $26.54 | No quote |
| 12 | COST | Com | 2.04% | - | 4,333,363 | $312.91M | $72.21 | No quote |
| 13 | USG | Corporation Com | 1.87% | - | 17,072,192 | $287.33M | No quote | No quote |
| 14 | JNJ | Com | 1.74% | - | 4,322,500 | $267.35M | $61.85 | No quote |
| 15 | GE | Com | 0.93% | - | 7,777,900 | $142.26M | $18.29 | No quote |
| 16 | UPS | Inc. Com | 0.68% | - | 1,429,200 | $103.73M | $72.58 | No quote |
| 17 | GSK | ADR | 0.39% | - | 1,510,500 | $59.24M | $39.22 | No quote |
| 18 | BK | Corp. Com | 0.35% | - | 1,793,915 | $54.18M | $30.20 | No quote |
| 19 | XOM | Com | 0.20% | - | 421,800 | $30.84M | $73.12 | No quote |
| 20 | IR | LTD. CLA | 0.20% | - | 636,600 | $29.95M | $47.05 | No quote |
| 21 | KO | Cola Com | 0.17% | - | 400,000 | $26.31M | $65.77 | No quote |
| 22 | GCI | Inc. Com | 0.17% | - | 1,740,231 | $26.26M | No quote | No quote |
| 23 | SNY | Aventis ADR | 0.10% | - | 488,500 | $15.74M | $32.23 | No quote |
| 24 | CDCO | Com | 0.07% | - | 1,218,199 | $10.96M | No quote | No quote |
| 25 | TMK | Corp. Com | 0.03% | - | 77,551 | $4.63M | No quote | No quote |